| S.No. |
Name of Candidate |
Thesis Title |
Area |
Start of Ph.D.-Year of Award |
Status |
| 1 |
Venkatesha Perumal R |
Design Synthesis and pharmacological evaluation of novel serotonergic 5HT3 receptor antagonist as potential agents for the treatment of cancer chemotherapy induced emesis |
Drug design and Development, Synthetic Medicinal Chemistry |
August, 2001 -September, 2005 |
Completed |
| 2 |
RajKumar R |
Behavioural Neuropharmacological Studies of Selected Serotonin Type-3 Receptor Antagonists as Potential Anti-depressants |
Neuropsycho-pharmacology division, (Drug discovery, standardization and development of new animal model) |
August, 2004 - March 2008 |
Completed |
| 3 |
Dilip Kumar Pandey |
Neurobehavioural and Neurochemical Evaluation of Selected Monoaminergic Modulators in Animal Models of Comorbid Depression and Anxiety |
Neuropsycho-pharmacology division, (Drug discovery, standardization and development of new animal model) |
August, 2007 - March 2011 |
Completed |
| 4 |
T. Devadoss |
Novel Quinoxaline Carboxamides: Design, Synthesis And Neuro-Pharmacological Evaluation as Anti-depressants, Anxiolytic And in the Management of Cancer Chemotherapy-Induced Nausea and Vomiting |
Drug design and Development, Synthetic Medicinal Chemistry |
December, 2007 - January 2012 |
Completed |
| 5 |
Shvetank Bhatt |
Behavioural and Neuropharmacological Screening of Potential Serotonergic Ligands for Co-morbid Depression, Anxiety and Related Disorders such as Cancer Chemotherapy Induced Nausea and Vomiting (CINV) |
Neuropsycho-pharmacology division, (Drug discovery, standardization and development of new animal model) |
October, 2008 - March, 2015 |
Completed |
| 6 |
Arghya K Dhar |
Novel Neuro-Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive dysfunction and Cancer Chemo- Therapy Induced Emesis: Design synthesis and Screening af Potential Serotonergic Modulators |
Drug design and Development, Synthetic Medicinal Chemistry |
January, 2010 - May, 2016 |
Completed |
| 7 |
Ankur Jindal |
Behavioral and Neuropharmacological Screening of Phosphodiesterase4 (PDE4) Inhibitors for Anti-depressant and Anxiolytic Potential |
Neuropsycho-pharmacology division, (Drug discovery, standardization and development of new animal model) |
January, 2010 - December, 2015 |
Completed |
| 8 |
Muthu V. Sudali |
Design, Synthesis and Pharmacological Evaluation of Novel Phosphodiesterase-IV inhibitors for their Anti-depressant and Anxiolytic Potential |
Drug design and Development, Synthetic Medicinal Chemistry |
June, 2010 - Octiber, 2015 |
Completed |
| 9 |
Sourabh Mundra |
Design, Synthesis and screening of Potential Anti-malarial Agents. |
Drug design and Development, Synthetic Medicinal Chemistry |
September, 2010 - June, 2017 |
Completed |
| 10 |
Deepali Gupta |
Behavioral and Neuro-pharmacological Screening of Potential Serotonergic Ligands for Co-morbid Depression |
Neuropsycho-pharmacology, (Drug discovery, standardization and development of new animal model) |
August, 2011 - April, 2017 |
Completed |
| 11 |
Yeshwant Kurhe |
Behavioral and Neuropharmacological Screening of Potential Serotonergic Modulators for Depression Comorbid with Obesity |
Neuropsycho-pharmacology, (Drug discovery, standardization and development of new animal model) |
January, 2012 - January, 2018 |
Completed |
| 12 |
Sushil Yadav |
Isolation and Characterization of Genetic Variants of Beta Casein From Cow Milk and to Study Their Effects on Osteoporosis |
Neuropsycho-pharmacology, Veterinary Pharmacology and Biotechnology |
August, 2012 - Oct., 2019 |
Completed |
An Institute of Eminence
